CELL INTELLIGENCE · 肿瘤细胞治疗研究

乳腺癌中巨噬细胞的代谢重编程：机制与治疗意义

Metabolic Reprogramming Of Macrophages In Breast Cancer: Mechanisms And Therapeutic Implications.

用于乳腺癌治疗的可注射水凝胶：从肿瘤微环境响应性与主动靶向药物递送到免疫治疗与诊疗一体化

Injectable Hydrogels for Breast Cancer Therapy: From Tumor Microenvironment-Responsive and Actively Targeted Drug Delivery to Immunotherapy and Theran

乳腺肿瘤微环境中的细胞竞争：癌症干细胞和免疫细胞在肿瘤进展及治疗意义中的新兴作用

Cell competition within breast tumor microenvironment: emerging role of cancer stem cells and immune cells in tumor progression and therapeutic implic

低剂量多西他赛重编程 CAR-T 细胞以增强实体瘤免疫

Low-dose docetaxel reprograms CAR T cells for enhanced solid tumor immunity.

这些发现描述了一种非遗传药理学预激活策略，具有潜在的可扩展性并与现有生产工艺兼容。该方法在临床前模型中展示了增强的 CAR-T 细胞对抗实体瘤屏障的性能，突显了化疗-免疫治疗协同作用的潜力。

犬乳腺癌自体树突状细胞疫苗疗法的开发

Development of Autologous Dendritic Cell Vaccine Therapeutics for Canine Mammary Cancer.

乳腺癌肽基靶向治疗的创新：从偶联物到精准递送

Innovations in peptide-based targeted therapies for breast cancer: From conjugates to precision delivery.

外泌体 lncRNA 作为分子开关驱动乳腺癌中巨噬细胞-肿瘤共进化

Exosomal lncRNAs as molecular switches driving macrophage-tumor co-evolution in breast cancer.

乳腺癌中的免疫检查点阻断与新兴联合平台：叙述性综述

Immune Checkpoint Blockade and Emerging Combination Platforms in Breast Cancer: A Narrative Review.

NK 细胞来源的细胞外囊泡在三阴性乳腺癌中表现出对整体肿瘤细胞和癌症干细胞的细胞毒性

Natural Killer Cell-Derived Extracellular Vesicles Exhibit Cytotoxicity Against Bulk Tumor Cells and Cancer Stem Cells in Triple-Negative Breast Cance

外泌体伪装壳聚糖/氧化锌/碳量子点纳米载体用于乳腺癌治疗中 pH 响应性阿霉素递送

Exosome-camouflaged chitosan/zinc oxide/carbon quantum dot nanocarriers for pH-responsive doxorubicin delivery in breast cancer treatment.